Zacks.com on MSN1mon
Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New DrugsHympavzi is Pfizer’s second hemophilia treatment to be ... Produodopa in the European Union in January. FDA Approves Roche’s ...
Alert FDA OKs Next-Gen Cologuard Test for CRC Screening In average-risk adults, Cologuard Plus demonstrated sensitivities of 95% for CRC and 43% for advanced precancerous lesions at 94% ...
Total knee replacement is an operation frequently needed by hemophilia patients ... depending on the patient's factor levels and other pharmacokinetic parameters such as recovery and half-life ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results